1 day ago

Space X IPO: 'Bad news' for tech stocks but what about Bitcoin?

SpaceX’s IPO could turn the Mag 7 into a Mag 8, with Tesla and SpaceX comprising 25% of the group's Bitcoin balance-sheet exposure...

1 day ago

DeFi hacks shake institutional confidence as risks outpace yields

Repeated bridge exploits and shrinking yields are making institutions question whether DeFi’s risks still justify the returns, say...

1 day ago

Spotify (SPOT) Stock Soars 16% Post-Investor Day: Why Wall Street Is Raising Pri...

Spotify (SPOT) surged 16% after Investor Day. Analysts raised targets to $650, citing AI expansion, strong Q1 margins, and premium...

1 day ago

Take-Two Interactive (TTWO) Stock Surges 5% on Strong Q4 Results and GTA VI Rele...

Take-Two (TTWO) stock rose 5% after beating Q4 estimates with $1.58B in net bookings and confirming GTA VI launches November 19, 2...

1 day ago

THORChain exploit tied to malicious node and GG20 flaw

The $10.7 million THORChain exploit was caused by a GG20 vulnerability, which allowed a malicious node to reconstruct a full priva...

1 day ago

Bitcoin Price Breaks 14-Year Support For The First Time In History, Analyst Pred...

Crypto analyst Phila has predicted that the Bitcoin price could see a massive decline to $55,000 after breaking a 14-year support...

1 day ago

IREN co-founder says AI’s biggest bottleneck is infrastructure, not chips

Dan Roberts outlines IREN’s strategy to build a vertically integrated AI platform spanning power, data centers, GPUs and enterpris...

1 day ago

State Street Expands Strive Asset Management (ASST) Holdings by 770% in $17.7M I...

State Street increases Strive Asset Management (ASST) stake by 770% with $17.7M purchase. Analysts target $38 as company holds 15,...

1 day ago

CoinDesk 20 performance update: NEAR surges 19.4% as index trades flat

Internet Computer (ICP), up 4.3% from Thursday, joined NEAR Protocol (NEAR) as a top performer.

1 day ago

Akari Therapeutics (AKTX) Stock Skyrockets 120% on Promising Cancer Drug Results

Akari Therapeutics (AKTX) stock soared 120% after-hours on preclinical data showing AKTX-101 works synergistically with adagrasib...